Source:http://linkedlifedata.com/resource/pubmed/id/17889361
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2007-9-24
|
pubmed:abstractText |
The BMT program at Princess Margaret Hospital performed 105 transplants using cryopreserved peripheral blood stem cells (PBSC) from related allogeneic donors. The outcomes were compared with those of a historic control of 106 patients transplanted with freshly procured PBSC. The infusions were tolerated with limited toxicity related to nausea/vomiting or bradycardia, correlated with the total amount of DMSO infused. The average viability of the total nucleated cell (TNC) population after thawing was 71%. The survival of clonogenic progenitors amounted to 75% for colony-forming unit-granulocyte-macrophage (CFU-GM), 69% for burst-forming units erythroid (BFU-E), and 78% for colony-forming units granulocyte-erythrocyte-monocyte-megakaryocyte (CFU-GEMM). In contrast, colony-forming units megakaryocyte (CFU-MEG) was significantly more cryosensitive with recovery rates of 39%. The number of viable CD34(+) cells transplanted was correlated with the number of transplanted viable CFU-GM (P < .001), BFU-E (P < .001), CFU-MEG (P < .001), and CFU-GEMM (P = .049), but not with the TNC dose. The number of transplanted CD34(+) cells was correlated with engraftment of neutrophils (P = .012) and platelets (P = .013). The outcomes of cryopreseved or fresh PBSC transplants (PBSCT) with respect to engraftment of neutrophils (P = .178) and platelets (P = .785), lymphocyte recovery (P = .926), acute (P = .113), and chronic graft-versus-host disease (P = .673), recurrence (P = .295), nonrelapse mortality (P = .340), and overall survival (P = .668) were not significantly different. It is therefore reasonable to consider the option of cryopreserved allografts.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1083-8791
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1233-43
|
pubmed:meshHeading |
pubmed-meshheading:17889361-Adolescent,
pubmed-meshheading:17889361-Adult,
pubmed-meshheading:17889361-Aged,
pubmed-meshheading:17889361-Cryopreservation,
pubmed-meshheading:17889361-Female,
pubmed-meshheading:17889361-Follow-Up Studies,
pubmed-meshheading:17889361-Graft Survival,
pubmed-meshheading:17889361-Graft vs Host Disease,
pubmed-meshheading:17889361-Hematopoietic Stem Cells,
pubmed-meshheading:17889361-Humans,
pubmed-meshheading:17889361-Lymphocyte Count,
pubmed-meshheading:17889361-Male,
pubmed-meshheading:17889361-Middle Aged,
pubmed-meshheading:17889361-Peripheral Blood Stem Cell Transplantation,
pubmed-meshheading:17889361-Retrospective Studies,
pubmed-meshheading:17889361-Survival Analysis,
pubmed-meshheading:17889361-Transplantation, Homologous
|
pubmed:year |
2007
|
pubmed:articleTitle |
Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts.
|
pubmed:affiliation |
Department of Hematology/Medical Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Canada.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|